Overview

An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects

Status:
Completed
Trial end date:
2016-11-09
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of perampanel given as an adjunctive therapy in participants with epilepsy. This study will be continued until perampanel is commercially available.
Phase:
Phase 3
Details
Lead Sponsor:
Eisai Co., Ltd.